Tilia Fiduciary Partners, Inc. Amgen Inc Transaction History

Tilia Fiduciary Partners, Inc.

$126 Million
Q2 2024

A detailed history of Tilia Fiduciary Partners, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Tilia Fiduciary Partners, Inc. holds 1,205 shares of AMGN stock, worth $388,817. This represents 0.3% of its overall portfolio holdings.

Number of Shares

1,205

Previous 1,252 3.75%

Holding current value

$388,817

Previous $355,000 5.92%

% of portfolio

0.3%

Previous 0.29%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$262.75 - $319.31 $12,349 - $15,007	-47 Reduced 3.75%	1,205 $376,000
Q1 2024 Apr 12, 2024	BUY	$268.87 - $324.56 $537 - $649	2 Added 0.16%	1,252 $355,000
Q4 2023 Jan 12, 2024	SELL	$255.7 - $288.46 $1,278 - $1,442	-5 Reduced 0.4%	1,250 $360,000
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $22,520 - $27,960	103 Added 8.94%	1,255 $337,000
Q2 2023 Jul 13, 2023	SELL	$214.27 - $253.37 $5,999 - $7,094	-28 Reduced 2.37%	1,152 $255,000
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $677 - $825	3 Added 0.25%	1,180 $285,000
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $458 - $582	2 Added 0.17%	1,177 $309,000
Q3 2022 Oct 26, 2022	BUY	$224.46 - $253.15 $448 - $506	2 Added 0.17%	1,175 $288,000
Q2 2022 Aug 01, 2022	BUY	$230.71 - $256.74 $24,224 - $26,957	105 Added 9.83%	1,173 $290,000
Q1 2022 Apr 18, 2022	BUY	$219.27 - $242.57 $438 - $485	2 Added 0.19%	1,068 $258,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $212,006 - $242,621	1,066 New	1,066 $240,000

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tilia Fiduciary Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tilia Fiduciary Partners, Inc. with notifications on news.

Account

Tilia Fiduciary Partners, Inc. Amgen Inc Transaction History